An evaluation of culture results during treatment for tuberculosis as surrogate endpoints for treatment failure and relapse.

by Patrick P J Phillips, Katherine Fielding, Andrew J Nunn
Published 2013-01-01

Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape.

by Patrick P J Phillips, Carole D Mitnick, James D Neaton, Payam Nahid, Christian Lienhardt, Andrew J Nunn
Published 2019-03-01

Prophylactic antibiotics to prevent cellulitis of the leg: economic analysis of the PATCH I & II trials.

by James M Mason, Kim S Thomas, Angela M Crook, Katharine A Foster, Joanne R Chalmers, Andrew J Nunn, Hywel C Williams
Published 2014-01-01

Organizational contextual factors that predict success of a quality improvement collaborative approach to enhance integrated HIV-tuberculosis services: a sub-study of the Scaling u...

by Santhanalakshmi Gengiah, Catherine Connolly, Nonhlanhla Yende-Zuma, Pierre M. Barker, Andrew J. Nunn, Nesri Padayatchi, Myra Taylor, Marian Loveday, Kogieleum Naidoo
Published 2021-09-01

A comparison of liquid and solid culture for determining relapse and durable cure in phase III TB trials for new regimens

by Patrick P. J. Phillips, Carl M. Mendel, Andrew J. Nunn, Timothy D. McHugh, Angela M. Crook, Robert Hunt, Anna Bateson, Stephen H. Gillespie
Published 2017-11-01

A multicentre randomised controlled trial and economic evaluation of continuous positive airway pressure for the treatment of obstructive sleep apnoea syndrome in older people: PRE...

by Alison McMillan, Daniel J Bratton, Rita Faria, Magda Laskawiec-Szkonter, Susan Griffin, Robert J Davies, Andrew J Nunn, John R Stradling, Renata L Riha, Mary J Morrell
Published 2015-06-01

A randomised controlled trial to compare the safety, effectiveness and cost-effectiveness of doxycycline (200 mg/day) with that of oral prednisolone (0.5 mg/kg/day) for initial tre...

by Joanne R Chalmers, Fenella Wojnarowska, Gudula Kirtschig, James Mason, Margaret Childs, Diane Whitham, Karen Harman, Anna Chapman, Shernaz Walton, Enno Schmidt, Thomas R Godec, Andrew J Nunn, Hywel C Williams
Published 2017-03-01

Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV status

by Conor D. Tweed, Angela M. Crook, Rodney Dawson, Andreas H. Diacon, Timothy D. McHugh, Carl M. Mendel, Sarah K. Meredith, Lerato Mohapi, Michael E. Murphy, Andrew J. Nunn, Patrick P. J. Phillips, Kasha P. Singh, Melvin Spigelman, Stephen H. Gillespie
Published 2019-08-01

Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study

by Conor Duncan Tweed, Genevieve Helen Wills, Angela M. Crook, Rodney Dawson, Andreas H. Diacon, Cheryl E. Louw, Timothy D. McHugh, Carl Mendel, Sarah Meredith, Lerato Mohapi, Michael E. Murphy, Stephen Murray, Sara Murthy, Andrew J. Nunn, Patrick P. J. Phillips, Kasha Singh, M. Spigelman, S. H. Gillespie
Published 2018-03-01

Spot sputum samples are at least as good as early morning samples for identifying Mycobacterium tuberculosis

by Michael E. Murphy, Patrick P. J. Phillips, Carl M. Mendel, Emily Bongard, Anna L. C. Bateson, Robert Hunt, Saraswathi Murthy, Kasha P. Singh, Michael Brown, Angela M. Crook, Andrew J. Nunn, Sarah K. Meredith, Marc Lipman, Timothy D. McHugh, Stephen H. Gillespie, On behalf of the REMoxTB Consortium
Published 2017-10-01

Toxicity associated with tuberculosis chemotherapy in the REMoxTB study

by Conor D. Tweed, Angela M. Crook, Evans I. Amukoye, Rodney Dawson, Andreas H. Diacon, Madeline Hanekom, Timothy D. McHugh, Carl M. Mendel, Sarah K. Meredith, Michael E. Murphy, Saraswathi E. Murthy, Andrew J. Nunn, Patrick P. J. Phillips, Kasha P. Singh, Melvin Spigelman, Genevieve H. Wills, Stephen H. Gillespie
Published 2018-07-01